跳至主要内容
临床试验/NCT03176966
NCT03176966已完成4 期

Ropinirole for the Treatment of Muscle Cramps in Patients With Cirrhosis

Vanderbilt University Medical Center1 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2016年9月2日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
31
试验地点
1
主要终点
Frequency of Muscle Cramps as Assessed by Patient Survey

研究概览

简要总结

The investigator's aim is to compare the efficacy of Ropinirole (Requip) to vitamin E in the treatment of muscle cramps in cirrhotic patients.

详细描述

Muscle cramps are common in liver disease, especially in patients with cirrhosis. Despite the association of muscle cramps with liver disease, there is a paucity of information regarding treatment in these patients. Many treatment options have been reported in the literature but no standard of treatment has been established.

Oral vitamin E replacement has been used successfully in the management of nocturnal muscle cramps in cirrhotic patients. Ropinirole is primarily used for treatment of restless leg syndrome. An off label trial of low dose Ropinirole in clinical practice has shown some success in providing relief of muscle cramps in patients with cirrhosis. This study will compare Ropinirole to vitamin E treatment in a prospective cross-over study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients at least 18 years of age in the Vanderbilt Medical Center Hepatology Practice
  • diagnosis of cirrhosis
  • Self report regular muscle cramping

排除标准

  • Patients without cirrhosis
  • Patients under the age of 18
  • Pregnant women

研究组 & 干预措施

Vitamin E then Ropinirole

Active Comparator

Patients will be provided with vitamin E, 400 international units (IU), at baseline. Patient demographics will be collected along with baseline lab data including magnesium, potassium, albumin, and total bilirubin levels. After 3 months, patients will be switched to Ropinirole. Surveys measuring muscle cramp frequency and intensity will be collected at baseline, 3 months, and 6 months.

干预措施: Vitamin E (Drug)

Vitamin E then Ropinirole

Active Comparator

Patients will be provided with vitamin E, 400 international units (IU), at baseline. Patient demographics will be collected along with baseline lab data including magnesium, potassium, albumin, and total bilirubin levels. After 3 months, patients will be switched to Ropinirole. Surveys measuring muscle cramp frequency and intensity will be collected at baseline, 3 months, and 6 months.

干预措施: Ropinirole (Drug)

Vitamin E then Ropinirole

Active Comparator

Patients will be provided with vitamin E, 400 international units (IU), at baseline. Patient demographics will be collected along with baseline lab data including magnesium, potassium, albumin, and total bilirubin levels. After 3 months, patients will be switched to Ropinirole. Surveys measuring muscle cramp frequency and intensity will be collected at baseline, 3 months, and 6 months.

干预措施: Muscle cramp survey (Other)

Ropinirole then Vitamin E

Active Comparator

Patients will be prescribed ropinirole at baseline. Patient demographics will be collected along with baseline lab data including magnesium, potassium, albumin, and total bilirubin levels. After 3 months, patients will be switched to vitamin E, 400 international units (IU). Surveys measuring muscle cramp frequency and intensity will be collected at baseline, 3 months, and 6 months.

干预措施: Vitamin E (Drug)

Ropinirole then Vitamin E

Active Comparator

Patients will be prescribed ropinirole at baseline. Patient demographics will be collected along with baseline lab data including magnesium, potassium, albumin, and total bilirubin levels. After 3 months, patients will be switched to vitamin E, 400 international units (IU). Surveys measuring muscle cramp frequency and intensity will be collected at baseline, 3 months, and 6 months.

干预措施: Ropinirole (Drug)

Ropinirole then Vitamin E

Active Comparator

Patients will be prescribed ropinirole at baseline. Patient demographics will be collected along with baseline lab data including magnesium, potassium, albumin, and total bilirubin levels. After 3 months, patients will be switched to vitamin E, 400 international units (IU). Surveys measuring muscle cramp frequency and intensity will be collected at baseline, 3 months, and 6 months.

干预措施: Muscle cramp survey (Other)

结局指标

主要结局

Frequency of Muscle Cramps as Assessed by Patient Survey

时间窗: 3 months

Compare the incidence of muscle cramps in patients using vitamin E versus ropinirole. Patients complete a survey that assesses the frequency of muscle cramps from once weekly or less to multiple episodes per day. Frequency scale is 0 to 3 with 0 being once weekly or less and 3 being multiple episodes a day. Survey is completed at the end of 3 months on study intervention.

次要结局

  • Muscle Cramp Severity as Assessed by Patient Survey(3 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Andrew Scanga

Principal Investigator

Vanderbilt University Medical Center

研究点 (1)

Loading locations...

相似试验